Process View
The directed movement of fatty acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Fatty acids are aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "fatty acid transport"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| INSR | insulin receptor | 0.647 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.576 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.379 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.356 | ||
| HP | haptoglobin | 0.328 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.281 | ||
| PEX19 | peroxisomal biogenesis factor 19 | 0.231 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.197 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.173 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.159 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.149 | ||
| APOC1 | apolipoprotein C-I | 0.092 | ||
| RLN3 | relaxin 3 | 0.082 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.069 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.062 | ||
| APOC3 | apolipoprotein C-III | 0.062 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.058 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.051 | ||
| LAT | linker for activation of T cells | 0.048 | ||
| ALB | albumin | 0.045 | ||
| CDCP1 | CUB domain containing protein 1 | 0.042 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.042 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.040 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.040 | ||
| MAPT | microtubule-associated protein tau | 0.035 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.035 | ||
| A2M | alpha-2-macroglobulin | 0.033 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.032 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.031 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.030 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.029 | ||
| TTR | transthyretin | 0.029 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.029 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.029 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.028 | ||
| PEX3 | peroxisomal biogenesis factor 3 | 0.027 | ||
| BDKRB2 | bradykinin receptor B2 | 0.027 | ||
| PEX14 | peroxisomal biogenesis factor 14 | 0.026 | ||
| DCTN1 | dynactin 1 | 0.026 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.025 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.023 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.023 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.022 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.022 | ||
| SLC34A1 | solute carrier family 34 (sodium phosphate), member 1 | 0.021 | ||
| XPO7 | exportin 7 | 0.021 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.021 | ||
| PRKCB | protein kinase C, beta | 0.021 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.021 | ||
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.020 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.020 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.020 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.019 | ||
| DSE | dermatan sulfate epimerase | 0.019 | ||
| NUMB | numb homolog (Drosophila) | 0.019 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.019 | ||
| RARA | retinoic acid receptor, alpha | 0.019 | ||
| AQP7 | aquaporin 7 | 0.018 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.018 | ||
| F11R | F11 receptor | 0.018 | ||
| FGA | fibrinogen alpha chain | 0.018 | ||
| GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.018 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.018 | ||
| S100A10 | S100 calcium binding protein A10 | 0.017 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.017 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.017 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.017 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.016 | ||
| ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | 0.016 | ||
| TREH | trehalase (brush-border membrane glycoprotein) | 0.016 | ||
| APOA2 | apolipoprotein A-II | 0.016 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.016 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.015 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.015 | ||
| IRS2 | insulin receptor substrate 2 | 0.015 | ||
| FOXN1 | forkhead box N1 | 0.015 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.015 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.015 | ||
| ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | 0.015 | Human Yeast | |
| TRAF5 | TNF receptor-associated factor 5 | 0.015 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.015 | Human | |
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.015 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.014 | ||
| LMO4 | LIM domain only 4 | 0.014 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.014 | ||
| APOC2 | apolipoprotein C-II | 0.014 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.014 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.014 | Rat | |
| IL1RN | interleukin 1 receptor antagonist | 0.014 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.014 | ||
| IRS1 | insulin receptor substrate 1 | 0.014 | Human | |
| SH2B1 | SH2B adaptor protein 1 | 0.014 | ||
| PPP2R5E | protein phosphatase 2, regulatory subunit B', epsilon isoform | 0.013 | ||
| ANXA5 | annexin A5 | 0.013 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.013 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.013 | ||
| SLC28A1 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | 0.013 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.013 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.013 | Human | |
| TRAF3 | TNF receptor-associated factor 3 | 0.013 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.013 | ||
| PCBD2 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 | 0.013 | ||
| FOXO3 | forkhead box O3 | 0.012 | ||
| GFAP | glial fibrillary acidic protein | 0.012 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.012 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.012 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.012 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.012 | ||
| PCBD1 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha | 0.012 | ||
| GLYAT | glycine-N-acyltransferase | 0.012 | ||
| TMEM173 | transmembrane protein 173 | 0.012 | ||
| KIAA1712 | KIAA1712 | 0.012 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.012 | ||
| CRYBB3 | crystallin, beta B3 | 0.012 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.012 | ||
| SORD | sorbitol dehydrogenase | 0.012 | ||
| PTPLB | protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b | 0.011 | ||
| SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 | 0.011 | Human | |
| PGRMC1 | progesterone receptor membrane component 1 | 0.011 | ||
| SH2D2A | SH2 domain containing 2A | 0.011 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.011 | ||
| NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) | 0.011 | ||
| ALPI | alkaline phosphatase, intestinal | 0.011 | ||
| GFRA4 | GDNF family receptor alpha 4 | 0.011 | ||
| ARRB1 | arrestin, beta 1 | 0.011 | ||
| PEX11B | peroxisomal biogenesis factor 11 beta | 0.011 | ||
| PXMP2 | peroxisomal membrane protein 2, 22kDa | 0.011 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.011 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.011 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.011 | ||
| TRIM9 | tripartite motif containing 9 | 0.011 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.011 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.011 | ||
| PRKCZ | protein kinase C, zeta | 0.011 | Human | |
| YIPF6 | Yip1 domain family, member 6 | 0.010 | ||
| PEX16 | peroxisomal biogenesis factor 16 | 0.010 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.010 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.010 | ||
| DPYS | dihydropyrimidinase | 0.010 | ||
| SIRT6 | sirtuin 6 | 0.010 | ||
| PDK4 | pyruvate dehydrogenase kinase, isozyme 4 | 0.010 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.010 | ||
| C8A | complement component 8, alpha polypeptide | 0.010 | ||
| C8B | complement component 8, beta polypeptide | 0.010 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.010 | ||
| CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 0.010 |